Epilepsy outcome data should be concerned not only with seizure frequency, but should also assess present potential as a function of preexisting capabilities. Reported findings on outcome are not consistent, al though view of epilepsy outcome since the 1970's is much more optimistic. The founding of an Institute of Epilep-tology can stimulate concerted action to provide the sci entific community with improved information on mea surement and analysis of the ways in which epilepsy changes the lives of the patient and those immediately involved.
Interest in the average or modal outcome of a disease can be motivated by very different reasons.
Either the professional is eager to know whether the strategy used to treat the disease or at least its con sequences has been successful or the health-care manager is eager to know whether investments pro vide sufficient return economically or politically and, preferably, both. Most important, however, is the wish to inform the patient of the predicted out come. Anyone affected by a disease is anxious about future prospects, how long a cure will take, or whether there will be any lasting sequelae. Basi cally, epileptic persons and their families want to know the prognosis.
SEIZURE REMITTANCE
Epilepsy is often a chronic disease* Comparison of prevalence and incidence data suggest that epilepsy persists 12 years on the average. Prevalence and incidence data are not in good agreement, how ever, and may vary by as much as 10-fold ( Table 1) .
The indication of 12-year duration is derived from the median incidence and the median prevalence. However, because epilepsy that occurs in the course of life is a life sentence, for some, others must carry the burden of epilepsy for a much shorter time. Can we predict for our patients the outcome of his or her epilepsy? What exactly are the problems associated with epilepsy.
IMPACT ON SOCIAL FUNCTIONING AND FAMILY
Forty years ago, I became committed to epileptology. One of my fellow students, an exceptionally gifted woman, had a sister who had postmalaria par tial epilepsy. Before onset of her seizures, this sis ter had performed much better academically than my fellow student herself, although the student later became a professor (however, not in epileptology, neurology, or psychiatry), whereas the sister with epilepsy could only perform menial work in a shel tered workshop. The impact of epilepsy on the whole family was clearly apparent. One day the ep ileptic sister had a seizure on the staircase and fell down the stairs. Her aging mother, who always walked behind her on the stairs, could no longer prevent the two of them from falling. The girl had to enter the residential section of a special center for epilepsy. She died a few years ago at the age of 58 in the Instituut voor Epilepsiebestrijding, Heemstede, The Netherlands, of a sudden unexplained death syndrome.
Persons with epilepsy must worry not only about seizures, but also about the impact of epilepsy on their functioning and their social circumstances. The prime characteristic of epilepsy and the one easiest to gauge is the occurrence of seizures. Can seizures be controlled? That epilepsy lasts 12 years on the average has no direct bearing on this ques tion because persons are considered to have epi lepsy not only if they have had at least two seizures in the past year but also as long as they are receiv ing anti epileptic drugs (AEDs), whether or not the seizures are in remission. The period of 12 years S36 EPILEPSY OUTCOME AND MEASUREMENT S37 Over that period, all cited studies about prognosis reported that approxi mately one-third of patients had their epilepsy con trolled by AEDs; two-thirds did not. A second point of reference is the book by Hauser and Hesdorffer (2), that quotes much better remission rates, some times ev en 80% (Table 3) .
H ow this discrepancy between the reports before the 1970s and published reports in the past 25 years can be explained is not clear. Some researchers be lieve that the advent of accurate monitoring of se rum levels of AEDs has shown that some persons rapidly metabolize AEDs, and thus do not benefit sufficiently from them. By examining the amount of AED in serum, one can also ascertain whether the patient has regularly ingested the prescribed AED; this issue might otherwise not be discussed with the attending physician. Multiple explanations for the discrepancy in reports of outcome of treatment can would be meaningful if one could discontinue pre scription of AEDs as soon as the seizures had been brought under control, but this cannot be done. The average rate of relapse after discontinuation of med ication is 30% (range 12-63%) ( Table 2) .
PROGNOSIS
In many respects, certainly with regard to seizure-induced risks, freedom from seizures is the most important outcome, and the consequences of chronic AED administration are of secondary im portance. How long must persons with epilepsy en dure seizures before the seizures are brought under control? The information available is not very sound. Sometimes it is difficult to determine how the outcome parameter was exactly defined. Usu ally the term remission is used, although according to Webster's dictionary, remission means abate ment, diminution-not complete arrest. Further more, whether the patients reported to be in remis sion are seizure-free because they are appropriately treated with AEDs or whether they can be consid ered as no longer having epilepsy because they re main seizure-free after discontinuation of medica tion is often not clearly reported.
With these caveats, let us examine what has hap pened over the years. A century ago, the only "'therapies5' for seizure control were bromides and be postulated, but all are rather difficult to prove or disprove. Nonetheless, if 0.6% of the population has epi lepsy, the latest data show that 0.12 have intracta ble epilepsy; e.g., the present census of England is 58 million people. Therefore, in that country, -70,000 people have intractable epilepsy. In this instance, we are considering only uncontrollable seizures. Unfortunately, a problem exists which can be illustrated by the model of compounded scales (Fig. 2) , as follows. To restore the balance disturbed by epilepsy, medication must be admin istered as a counter-weight. Addition of medication will place a greater load on the " spring/' which will partly reduce the improvement achieved by the medication. It is indeed a nuisance that since the arm of the scale is prevented from dipping by a stopper, administration of too much medication as a counter-measure for the seizures will not be no ticed. That is, epilepsy is a disorder characterized by paroxysmal seizures, and only after a time will it be clear whether the increase in dosage has actually been effective. Titration of the exact dosage to maintain seizure control is therefore very difficult. Thus, many patients may be seizure-free while con suming an excessive dosage of medicine. A feature not disclosed by this model, which would be equiv alent to a shrinking of the scale, is the phenomenon Epilepsia, Voi. 36, Suppl, 1, 1995 EPILEPSY OUTCOME AND MEASUREMENT S39 of tolerance for the side effects of the AEDs, which unfortunately is often a pseudo tolerance; the pa tient is no longer aware of diminished capacities. When the epilepsy load is so heavy that the amount of medication to counterbalance its effect is intolerable, or when an unnecessary amount of medication has been administered, the attention of the treating physician should be directed at the as sessment of the quality of life (QOL) provided. QOL outcome measures should also reveal whether a diminished quality exists, of which the patient is no longer aware, such as that induced by pseudo tolerance. However, the QOL of a person with ep ilepsy is not determined only by proper pharmaco therapy. Imagine what it means for a person never to know when the next seizure will occur. Think of all the precautions one must take, and the restric tions that are imposed, sometimes reasonably and sometimes unreasonably, because society is not able to make the fine distinctions that result from patients with epilepsy presenting with different con sequences. Furthermore, the cause of the epilepsy may have altered brain function, including between Cases that were experiencing problems were re ported in 10-67% of different series, depending on the study group characteristics (Table 4 ). However, the WPSI is not truly a desk instrument that permits the attending physician to gauge the psychosocial level of the patient. Nor does the outcome on the WPSI immediately clarify the reasons for the score.
This volume commemorates the founding of the London Institute of Epileptology. This occurs at a most appropriate moment. The outline of the field to be attacked has been charted, and tools with which a multidisciplinary team should be able to address it have been developed. At present, the prognosis for an individual person who has a first seizure is difficult to define. However, the progno sis that many persons with epilepsy will be very grateful that the London Institute of Epileptology » has been established is crystal clear.
